Pre-Operative Chemotherapy Followed by Surgery for N2 Non-Small Cell Lung Cancer: A 15-Year Experience

被引：0
|
作者：
Spicer, Jonathan D. [1 ]
Shewale, Jitesh [1 ]
Correa, Arlene M. [1 ]
Heymach, John V. [2 ]
Antonoff, Mara B. [1 ]
Hofstetter, Wayne [1 ]
Mehran, Reza [1 ]
Roth, Jack [1 ]
Rice, David [1 ]
Sepesi, Boris [1 ]
Vaporciyan, Ara A. [1 ]
William, William [2 ]
Walsh, Garrett [1 ]
Swisher, Stephen [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Thorac & Cardiovasc Surg, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
lung cancer; Surgery; chemotherapy; N2;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.03-017
引用
收藏
页码：S571 / S572
页数：2
相关论文
共 50 条
  • [21] Prognostic factors and survival in pre- and per-operative detected and resected N2 non-small cell lung cancer
    Van Velzen, E
    CHEST, 2005, 128 (04) : 312S - 313S
  • [22] Pre-operative Plasma Markers in Colorectal Cancer Pathology and 15-year Survival
    Baker, E.
    Robinson, N.
    Tabaqchali, M.
    Leaper, D.
    BRITISH JOURNAL OF SURGERY, 2018, 105 : 139 - 139
  • [23] Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N2 non-small cell lung cancer
    Date, H
    Kiura, K
    Ueoka, H
    Tabata, M
    Aoe, M
    Andou, A
    Shibayama, T
    Shimizu, N
    BRITISH JOURNAL OF CANCER, 2002, 86 (04) : 530 - 533
  • [24] Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N2 non-small cell lung cancer
    H Date
    K Kiura
    H Ueoka
    M Tabata
    M Aoe
    A Andou
    T Shibayama
    N Shimizu
    British Journal of Cancer, 2002, 86 : 530 - 533
  • [25] Recent Clinical Outcomes of Upfront Surgery Followed by Adjuvant Therapy for Resectable Pathological N2 Non-Small Cell Lung Cancer
    Yun, J. K.
    Chong, Y.
    Jeong, Y. H.
    Lee, H. P.
    Bok, J. S.
    Lee, G. D.
    Kim, H. R.
    Kim, Y.
    Kim, D. K.
    Park, S.
    Choi, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S410 - S411
  • [26] How Effective Is Neoadjuvant Therapy Followed by Surgery for Pathologic Single-Station N2 Non-Small Cell Lung Cancer?
    Keshava, Hari B.
    Tan, Kay See
    Dycoco, Joseph
    Livschitz, Jennifer
    Bott, Matthew J.
    Huang, James
    Rusch, Valerie W.
    Isbell, James M.
    Molena, Daniela
    Bains, Manjit S.
    Jones, David R.
    Rocco, Gaetano
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2021, 33 (01) : 206 - 216
  • [27] Post-Operative Radiotherapy in completely resected Non-Small Cell Lung Cancer and N2 involvement
    Pires, A. M.
    Figueiredo, T.
    Conde, S.
    Ferreira, C.
    Laranja, A.
    de Castro, B.
    Sousa, F.
    Sarandao, S.
    Cardia, J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S955 - S956
  • [28] Results of surgery for non-small cell lung cancer with N2 involvement unsuspected before thoracotomy
    Jimenez, Marcelo F.
    Varela, Gonzalo
    Novoa, Nuria M.
    Aranda, Jose Luis
    ARCHIVOS DE BRONCONEUMOLOGIA, 2008, 44 (02): : 65 - 69
  • [29] Results of initial surgery for clinical single station N2 non-small cell lung cancer
    Nakagawa, Kazuo
    Ohde, Yasuhisa
    Okumura, Takehiro
    Kondo, Haruhiko
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S571 - S572
  • [30] Perioperative therapies in surgical non N2 non-small cell lung cancer
    Ruppert, Anne-Marie
    Lavole, Armelle
    Assouad, Jalal
    Cadranel, Jacques
    Wislez, Marie
    BULLETIN DU CANCER, 2017, 104 (01) : 79 - 85
12345